Source: PR Newswire Dermavant Sciences, a biopharmaceutical company focused on developing innovative therapies for dermatologic conditions, today announced the appointment…...
Latest News
Encore makes pipeline play, licensing psoriasis drug from Dr. Reddy’s
Source: FierceBiotech Encore Dermatology, formed two years ago as a vehicle for three ex-Valeant products, has picked up a late-stage…...
Prollenium Medical Technologies Inc. announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler
Source: PR Newswire Prollenium Medical Technologies Inc., a leading medical device manufacturer, announced today its United States (U.S.) Food and…...
Has the Brent Saunders price-hike limit become a de facto pharma rule?
Source: Nearly one year ago, as the pharma industry was beset by pricing scrutiny, Allergan CEO Brent Saunders pledged to…...
Fortress Biotech Announces Filing of Provisional Patent Application for Caelum Biosciences’ CAEL-101
Source: Globe Newswire Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and…...
Allergan to Acquire Keller Medical, Inc., Adding Keller Funnel® to Company’s Leading Plastic Surgery Portfolio
Source: PR Newswire Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that Allergan's wholly-owned subsidiary, Allergan Sales…...
Stuart Raetzman Appointed CEO of Nestlé Skin Health
Source: Business Wire Nestlé has appointed Stuart Raetzman as CEO of Nestlé Skin Health, effective immediately. “I am very pleased…...
ALPHAEON Submits Biologics License Application for DWP-450 Neuromodulator
Source: PR Newswire ALPHAEON Corporation (www.alphaeon.com) today announced that its wholly-owned subsidiary, Evolus Inc., submitted a Biologics License Application (BLA)…...
Ex-Kythera team raises $40M for dermatology clinical trials
Source: FierceBiotech Sienna Biopharmaceuticals has raised $40 million to advance its pipeline of clinical-phase aesthetic and dermatology assets. The Series B…...
Cardinal Health to fork over $6.1B for three Medtronic units
Source: FierceBiotech Cardinal Health will acquire Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency units for $6.1 billion in…...